Published February 9, 2026
| Version v1
Journal article
Open
Comparative Analysis of early surfactant administration versus Standard Care in neonatal sepsis
Authors/Creators
- 1. Krishna Research Center for Neonatology
- 2. Ebro Research Center for Pediatric Research
- 3. Amur Center for Pediatric Research
Description
Background: Neonatal sepsis frequently produces a secondary surfactant dysfunction syndrome that resembles primary
respiratory distress syndrome, because inflammatory mediators and proteinaceous exudate inactivate pulmonary surfactant
regardless of gestational maturity.
Objective: This review synthesizes evidence comparing early exogenous surfactant administration with standard supportive care
alone in neonates with sepsis-associated respiratory failure.
Methods: We synthesized randomized trials, multicenter cohorts, and Cochrane reviews addressing surfactant timing, delivery
technique, and respiratory outcomes in septic and infection-associated neonatal respiratory failure.
Findings: Early surfactant reduces oxygenation index and need for extracorporeal support in term and near-term infants with
sepsis-related respiratory failure, with the greatest benefit when given before severe decompensation; less invasive delivery
extends this advantage to spontaneously breathing preterm infants, though surfactant inactivation by serum proteins blunts the
response compared with primary respiratory distress syndrome.
Conclusions: Early, protocol-driven surfactant administration alongside antimicrobial therapy and lung-protective ventilation
offers measurable benefit over standard care alone in neonatal sepsis, but optimal timing and patient selection remain
incompletely defined.